AGGRESSIVE FIBROMATOSIS
Clinical trials for AGGRESSIVE FIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE FIBROMATOSIS trials appear
Sign up with your email to follow new studies for AGGRESSIVE FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare tumor in japanese patients
Disease control OngoingThis phase 2 study tests the drug nirogacestat in 20 Japanese adults with desmoid tumors that are growing. The goal is to see if the drug can shrink tumors or stop them from getting worse. Participants take nirogacestat as an oral tablet, and researchers will monitor tumor respon…
Matched conditions: AGGRESSIVE FIBROMATOSIS
Phase: PHASE2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
French launch largest study of rare tumor disease
Knowledge-focused OngoingThis study aims to create the largest French database of people diagnosed with aggressive fibromatosis, a rare tumor that grows in connective tissue. Researchers will collect tissue samples, medical history, and genetic information from 628 participants across France. The goal is…
Matched conditions: AGGRESSIVE FIBROMATOSIS
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC